Cargando…
Genomic and signalling pathway characterization of the NZM panel of melanoma cell lines: A valuable model for studying the impact of genetic diversity in melanoma
Melanoma is a disease associated with a very high mutation burden and thus the possibility of a diverse range of oncogenic mechanisms that allow it to evade therapeutic interventions and the immune system. Here, we describe the characterization of a panel of 102 cell lines from metastatic melanomas...
Autores principales: | Tran, Khanh B., Gimenez, Gregory, Tsai, Peter, Kolekar, Sharada, Rodger, Euan J., Chatterjee, Aniruddha, Jabed, Anower, Shih, Jen‐Hsing, Joseph, Wayne R., Marshall, Elaine S., Wang, Qian, Print, Cristin G., Eccles, Michael R., Baguley, Bruce C., Shepherd, Peter R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818249/ https://www.ncbi.nlm.nih.gov/pubmed/32567790 http://dx.doi.org/10.1111/pcmr.12908 |
Ejemplares similares
-
Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK
por: Tran, Khanh B., et al.
Publicado: (2021) -
Comparison of Global DNA Methylation Patterns in Human Melanoma Tissues and Their Derivative Cell Lines
por: Rodger, Euan J., et al.
Publicado: (2021) -
Establishment of cultured primary acral melanoma cells and animal models for Chinese patients
por: Hu, Rui, et al.
Publicado: (2021) -
Inhibitors of pan-PI3K Signaling Synergize with BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth
por: Sweetlove, Melanie, et al.
Publicado: (2015) -
Transcriptional Reprogramming and Constitutive PD-L1 Expression in Melanoma Are Associated with Dedifferentiation and Activation of Interferon and Tumour Necrosis Factor Signalling Pathways
por: Ahn, Antonio, et al.
Publicado: (2021)